Key Elements of the Biotech Market

  • Alexandra Perju-Mitran


Addressing the uncontrollable factors influencing the European biotech market is critical to the commercial success of emerging biotech companies, as the accelerating pace of biotechnological research allows for the development and implementation of new products and services. Modern biotechnology demands rigorous oversight of macroenvironmental factors, as each of these uncontrollable macroenvironmental factors affect new ventures in biotech; change occurs when companies manage to favorably respond to the challenges imposed by each factor, constructing a different representation for the public, and thus shaping the development of biotechnology itself.

With biotechnology used in a wide variety of sectors, it is imperative to analyze market factors in several fields, with focus on one hand on specific European factors and on the other hand on global factors that either pose threats or opportunities for new ventures.

As in all cases, factors of the macroenvironment are beyond the influence capacities of individual companies and will always present themselves as either opportunities or threats. Given the specificity of biotechnology, there will always be needs that are not catered to.


European biotech External factors Biotech start-up Social factors Economic factors Political factors Legal factors Technological factors Biotech marketing  


  1. Aerni P, Gagalac F, Scholderer J (2015) The role of biotechnology in combating climate change: a question of politics? Sci Public Policy 43(1):13–28CrossRefGoogle Scholar
  2. Amin L, Jahi JM, Nor ARM, Osman M, Mahadi NM (2007) Public acceptance of modern biotechnology. Asia Pac J Mol Biol Biotechnol 15(2):39–51Google Scholar
  3. Bernauer T, Meins E (2003) Technological revolution meets policy and the market: explaining cross-national differences in agricultural biotechnology regulation. Eur J Polit Res 42(5):643–683CrossRefGoogle Scholar
  4. Gaskell G, Alum N, Baouer M, Durant J, Allansdottir A, Bonfadelli H, Boy D, Cheveigne DS, Fjaestad B, Gutteling JM, Hampel J, Jelsoe E, Jesuino JG, Kohring M, Kronberger N, Midden C, Nielsen TH, Przestalski A, Rusanen T, Sakellaris G, Torgersen H, Twardowski T, Wagner W (2000) Biotechnology and the European public. Nat Biotechnol (18):935–938CrossRefGoogle Scholar
  5. Internet World Stats (2019). Accessed 10 Mar 2019
  6. Kearney C (2018) Regulation and market influences on innovation in biotechnology. J Commer Biotechnol 24(3):57–62Google Scholar
  7. Knight ERW (2010) The economic geography of clean tech venture capital. Oxford University Working Paper Series in Employment, Work and Finance. Available at SSRN: or doi:
  8. Kotler P, Armstrong G (2015) Principles of marketing-global edition. PearsonGoogle Scholar
  9. Kurzer P, Cooper A (2007) Consumer activism, EU institutions and global markets: the struggle over biotech foods. J Public Policy 27(2):103–128CrossRefGoogle Scholar
  10. Pardo R, Calvo F (2006) Are Europeans really antagonistic to biotech? Nat Biotechnol 24(4):393–396CrossRefGoogle Scholar
  11. Savadori L, Savio S, Nicotra E, Rumiati R, Finucane M, Slovic P (2004) Expert and public perception of risk from biotechnology. Risk Anal 24(5):1289–1299CrossRefGoogle Scholar
  12. Tiago MTPMB, Veríssimo JMC (2014) Digital marketing and social media: Why bother? Bus Horiz 57(6):703–708CrossRefGoogle Scholar
  13. Tyagi P, Kumar A, Sengar RS (2018) The opportunities to develop a successful entrepreneurship and business model in biotechnology: an overview. J Commer Biotechnol 24(3):63–68Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Alexandra Perju-Mitran
    • 1
  1. 1.Faculty of Management-MarketingRomanian-American UniversityBucharestRomania

Personalised recommendations